http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013202634-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_803023bbcbd1fcfd4f7ad657d38cae1a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate | 2013-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b3d1df8c6b4b50a9628433283de9b34 |
publicationDate | 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2013202634-B2 |
titleOfInvention | Method of identifying disease risk factors |
abstract | Provided herein is a method for identifying a genetic variant that is associated with development of a condition of interest (e.g,, Alzheimer's disease), and genetic variants so identified. Methods of treatment with an active agent (e.g., with a particular active agent and/or at an earlier age) is also provided, upon detecting a genetic variant described herein. In some embodiments, the genetic variant is a deletion/insertion polymorphism (DIP) of the TOMM40 GENE. Kits for determining if a subject is at increased risk of developing late onset Alzheimer's disease is also provided. Kits for determining if a subject is responsive to treatment for a condition of interest with an active agent are further provided. |
priorityDate | 2008-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 250.